Package leaflet

LACRINORM “0,01%+0,2% ophthalmic gel”

Tube 10 g
Composition
100 g of gel contain: Benzalkonium chloride 0.01 g; Polycarbophil 0.2 g
Excipients: Sorbitol; water for injections
Pharmaceutical form
Ophthalmic gel, 10 g tube
Pharmacotherapeutic category
Disinfectant for ophthalmic use. Lubricant
Marketing Authorization Holder
FARMIGEA S.p.A., Via G.B. Oliva 6/8, 56121 – Pisa
Exclusive distributor for sale: OFTAGEN Srl – Via G.B. Oliva 6, 56121 - Pisa
Manufactured and controlled by
FARMIGEA SpA Via G. B. Oliva 8, 56121 - Pisa
Therapeutic indications
Disinfection of the ocular mucosa. Lubricant and moisturizer for dry eye due to insufficient tear production (Dry Eye Syndrome)
Contraindications
Hypersensitivity to the components.
Precautions for use
This product is for external use only. The use, especially prolonged, of topical products may lead to sensitization phenomena; in such cases, discontinue treatment and consult a physician to initiate appropriate therapy.
Do not use LACRINORM while wearing contact lenses, but between periods of lens wear. If application is necessary, wait 15 minutes before inserting contact lenses.
Interactions
Avoid concomitant use of other antiseptics and ocular detergents.
Warnings
Do not use for prolonged treatments; if no improvement is observed after a short period of treatment, consult a physician. Accidental ingestion of certain disinfectants may have serious, sometimes fatal, consequences.
Dosage, method and duration of administration
1 drop into the conjunctival sac 3-4 times daily (the last dose before bedtime).
During application, hold the tube vertically, not at an angle, to ensure a consistent drop.
Do not exceed the recommended dosage.
Undesired effects
In some cases, intolerance (burning or irritation) may occur, although it is generally transient and without serious consequences, and does not require treatment modification.
Immediately after application, a slight temporary blurring of vision may occur due to the gel's viscosity; this blurring disappears rapidly.
Inform your physician or pharmacist if any adverse effects not described in this leaflet occur.
Attention
Do not use the medicine after the expiry date stated on the packaging.
The product must not be used more than 30 days after first opening the container.
Keep the medicine out of the reach of children